IGC Pharma (IGC) Free Cash Flow (2010 - 2025)
IGC Pharma (IGC) reported Free Cash Flow of -$2.1 million for Q3 2025, down 106.73% year-over-year from $31.5 million in Q3 2024, and down 49.75% quarter-over-quarter from -$1.4 million in Q2 2025.
IGC Pharma (IGC) Free Cash Flow (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Free Cash Flow data on file, last reported at -$2.1 million in Q3 2025.
- Free Cash Flow for Q3 2025 came in at -$2.1 million, down 106.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.5 million (up 27.98% YoY), and the FY2026 annual result was -$1.2 million, up 75.06% from the prior year.
- Free Cash Flow slipped to -$2.1 million in Q3 2025 per IGC's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$541000.0 in Q1 2024 and troughed at -$2.6 million in Q1 2021.
- A 5-year average of -$1.7 million and a median of -$1.7 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow soared 64.45% in 2024, then tumbled 106.73% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$2.4 million in 2021, then advanced by 8.94% to -$2.2 million in 2022, then grew by 25.78% to -$1.7 million in 2023, then advanced by 18.79% to -$1.3 million in 2024, then sank by 57.66% to -$2.1 million in 2025.
- Business Quant data shows IGC's Free Cash Flow at -$2.1 million in Q3 2025, -$1.4 million in Q2 2025, and -$748000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 63,220.27 |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.12 Mn |
| Sep 30, 2025 | -2.12 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Mar 31, 2025 | -748,000.00 |
| Mar 31, 2025 | -748,000.00 |
| Dec 31, 2024 | -1.34 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | -541,000.00 |
| Mar 31, 2024 | -541,000.00 |
| Dec 31, 2023 | -1.66 Mn |
| Dec 31, 2023 | -1.66 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -1.49 Mn |